Puma Biotechnology, Inc.
PBYI
$2.95
-$0.055-1.83%
NASDAQ
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -26.65% | 71.06% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -26.65% | 71.06% | |||
| Cost of Revenue | -52.16% | 173.01% | |||
| Gross Profit | -12.22% | 41.24% | |||
| SG&A Expenses | -1.17% | -32.65% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -21.81% | 18.68% | |||
| Operating Income | -39.47% | 1,113.26% | |||
| Income Before Tax | -40.62% | 596.46% | |||
| Income Tax Expenses | -2,528.52% | -23.02% | |||
| Earnings from Continuing Operations | -4.98% | 548.60% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -4.98% | 548.60% | |||
| EBIT | -39.47% | 1,113.26% | |||
| EBITDA | -35.06% | 3,323.46% | |||
| EPS Basic | -5.16% | 542.00% | |||
| Normalized Basic EPS | -40.72% | 589.39% | |||
| EPS Diluted | -4.10% | 537.10% | |||
| Normalized Diluted EPS | -40.89% | 587.71% | |||
| Average Basic Shares Outstanding | 0.18% | 1.48% | |||
| Average Diluted Shares Outstanding | 0.48% | 1.82% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||